BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23056605)

  • 1. How metal substitution affects the enzymatic activity of catechol-o-methyltransferase.
    Sparta M; Alexandrova AN
    PLoS One; 2012; 7(10):e47172. PubMed ID: 23056605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural mechanism of S-adenosyl methionine binding to catechol O-methyltransferase.
    Tsao D; Diatchenko L; Dokholyan NV
    PLoS One; 2011; 6(8):e24287. PubMed ID: 21904625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A semiempirical study on inhibition of catechol O-methyltransferase by substituted catechols.
    Ovaska M; Yliniemelä A
    J Comput Aided Mol Des; 1998 May; 12(3):301-7. PubMed ID: 9749372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of catechol O-methyltransferase.
    Vidgren J; Svensson LA; Liljas A
    Nature; 1994 Mar; 368(6469):354-8. PubMed ID: 8127373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacophore-based virtual screening of catechol-o-methyltransferase (COMT) inhibitors to combat Alzheimer's disease.
    Patel CN; Georrge JJ; Modi KM; Narechania MB; Patel DP; Gonzalez FJ; Pandya HA
    J Biomol Struct Dyn; 2018 Nov; 36(15):3938-3957. PubMed ID: 29281938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deuterium Solvent Kinetic Isotope Effect on Enzymatic Methyl Transfer Catalyzed by Catechol O-methyltransferase.
    Zipeng Z; Fangya L; Jianyu Z
    Protein Pept Lett; 2023; 30(4):351-359. PubMed ID: 36852820
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Czarnota S; Baxter NJ; Cliff MJ; Waltho JP; Scrutton NS; Hay S
    Biomol NMR Assign; 2017 Apr; 11(1):57-61. PubMed ID: 27981425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of COMT Inhibitors Using Machine Learning and Molecular Dynamics Methods.
    Roy RK; Patra N
    J Phys Chem B; 2022 May; 126(19):3477-3492. PubMed ID: 35533359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extra virgin olive oil phenolic oleacein is a dual substrate-inhibitor of catechol-O-methyltransferase.
    Cuyàs E; Verdura S; Lozano-Sánchez J; Viciano I; Llorach-Parés L; Nonell-Canals A; Bosch-Barrera J; Brunet J; Segura-Carretero A; Sanchez-Martinez M; Encinar JA; Menendez JA
    Food Chem Toxicol; 2019 Jun; 128():35-45. PubMed ID: 30935952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of ortho- and meta-nitrated inhibitors of catechol-O-methyltransferase: interactions with the active site and regioselectivity of O-methylation.
    Palma PN; Rodrigues ML; Archer M; Bonifácio MJ; Loureiro AI; Learmonth DA; Carrondo MA; Soares-da-Silva P
    Mol Pharmacol; 2006 Jul; 70(1):143-53. PubMed ID: 16618795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a novel human catechol-O-methyl-transferase mutant with triplet point mutations.
    Bai HW; Wang P; Zhu BT
    Int J Mol Med; 2008 Dec; 22(6):769-79. PubMed ID: 19020775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular recognition at the active site of catechol-O-methyltransferase (COMT): adenine replacements in bisubstrate inhibitors.
    Ellermann M; Paulini R; Jakob-Roetne R; Lerner C; Borroni E; Roth D; Ehler A; Schweizer WB; Schlatter D; Rudolph MG; Diederich F
    Chemistry; 2011 May; 17(23):6369-81. PubMed ID: 21538606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme.
    Lotta T; Vidgren J; Tilgmann C; Ulmanen I; Melén K; Julkunen I; Taskinen J
    Biochemistry; 1995 Apr; 34(13):4202-10. PubMed ID: 7703232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The relationship between catechol O-methyltransferase and diseases].
    Qian XK; Xia YL; Dou TY; Hou J; Ma H; Ge GB; Yang L; Bi XL
    Yao Xue Xue Bao; 2016 Apr; 51(4):543-51. PubMed ID: 29859522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of catechol-O-methyltransferase in catechol-enhanced erythroid differentiation of K562 cells.
    Suriguga ; Li XF; Li Y; Yu CH; Li YR; Yi ZC
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):635-43. PubMed ID: 24141029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theoretical modeling of enzyme catalytic power: analysis of "cratic" and electrostatic factors in catechol O-methyltransferase.
    Roca M; Martí S; Andrés J; Moliner V; Tuñón I; Bertrán J; Williams IH
    J Am Chem Soc; 2003 Jun; 125(25):7726-37. PubMed ID: 12812514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational Investigation of the Interplay of Substrate Positioning and Reactivity in Catechol O-Methyltransferase.
    Patra N; Ioannidis EI; Kulik HJ
    PLoS One; 2016; 11(8):e0161868. PubMed ID: 27564542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detoxication of structurally diverse polycyclic aromatic hydrocarbon (PAH) o-quinones by human recombinant catechol-O-methyltransferase (COMT) via O-methylation of PAH catechols.
    Zhang L; Jin Y; Chen M; Huang M; Harvey RG; Blair IA; Penning TM
    J Biol Chem; 2011 Jul; 286(29):25644-54. PubMed ID: 21622560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structures of the apo and holo form of rat catechol-O-methyltransferase.
    Tsuji E; Okazaki K; Isaji M; Takeda K
    J Struct Biol; 2009 Mar; 165(3):133-9. PubMed ID: 19111934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separation methods for catechol O-methyltransferase activity assay: physiological and pathophysiological relevance.
    Pihlavisto P; Reenilä I
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Dec; 781(1-2):359-72. PubMed ID: 12450669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.